AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies

Author： Van Den Neste Eric   Van den Berghe Georges   Bontemps Franççoise  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.4, 2010-04, pp. : 571-578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies

By Martelli Alberto M   Chiarini Francesca   Evangelisti Camilla   Ognibene Andrea   Bressanin Daniela   Billi Anna Maria   Manzoli Lucia   Cappellini Alessandra   McCubrey James A  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 729-742

Informa Healthcare

Access to resources Recommend Favorite

Acadesine: AICA Riboside, ARA 100, Arasine, GP 1 110

By Adis International Limited  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 169-175

Adis International

Access to resources Recommend Favorite

AMP-Activated Protein Kinase and Type 2 Diabetes

By  

Current Medicinal Chemistry, Vol. 13, Iss. 5, 2006-03 ,pp. : 583-589

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy

By Chan Anita Y.M   Dyck Jason R.B  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 1, 2005-01 ,pp. : 24-28

NRC Research Press

Access to resources Recommend Favorite

Prolonged AMP-activated protein kinase induction impairs vascular functions

By Ertuna Elif  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1025-1030

NRC Research Press

Access to resources Recommend Favorite